By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Biovail Pharmaceuticals, Inc. 

700 Route 202/206

North Bridgewater  New Jersey  08807  U.S.A.
Phone: 908-927-1400 Fax: 908-927-1401



Company News
Valeant Pharmaceuticals International (VRX) and Biovail Pharmaceuticals, Inc. Announce Valeant's Intention to Declare a Special Dividend to Stockholders Upon Obtaining Shareholder Approval, Financing and Satisfaction of Other Closing Conditions 9/22/2010 9:23:20 AM
Biovail Pharmaceuticals, Inc., Santhera Pharmaceuticals AG Strike Parkinson's Drug Deal; Santhera Could Pay up to $184 Million 8/24/2009 6:32:40 AM
Biovail Pharmaceuticals, Inc. Cuts Dividend 76 Percent as Profit Shrinks 5/6/2009 7:13:40 AM
Biovail Pharmaceuticals, Inc. Launches Ralivia(TM) to Canadian Physicians 11/1/2007 12:40:36 PM
Biovail Pharmaceuticals, Inc. To Present At The UBS Warburg Global Specialty Pharmaceuticals Conference 4/21/2006 12:44:06 PM
Flamel Technologies (FLML) Announces Termination Of Licensing Agreement With Biovail Laboratories Inc. For Genvir And Recovery Of Rights10/19/2005 5:12:55 PM
Biovail (BVF) Launches Tiazac XC To Canadian Physicians10/19/2005 5:12:33 PM
Biovail (BVF) Confirms Receipt Of Notification Of ANDA Submission For Wellbutrin XL; BVF Stock Down10/19/2005 5:12:14 PM
Webcast Alert: Biovail (BVF) Presentation At Informed Investors International Pharmaceuticals Virtual Forum To Be Webcast On Tuesday, November 9, 2004, 3:30 PM ET10/19/2005 5:12:08 PM
Biovail (BVF) Eyes Splitting Chairman, CEO Roles10/19/2005 5:11:07 PM